PZZA vs REGN
Papa John's International Inc (PZZA) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Papa John's International Inc (PZZA) is a restaurants company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PZZA revenue for 2024-12-29 was $2.06B. Net income was $84.2M. Revenue was down 3.6% from 2023-12-31 to 2024-12-29. PZZA currently screens at market cap $1.20B and trailing P/E 43.9.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PZZA currently screens at market cap $1.20B and trailing P/E 43.9. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PZZA and REGN stock pages for the full models.
Not investment advice.